Hypertension and Heart Failure Medications. Dr William Dooley
|
|
|
- Magdalen Green
- 9 years ago
- Views:
Transcription
1 Hypertension and Heart Failure Medications Dr William Dooley
2 Plan Heart Failure Acute vs. chronic Mx Hypertension Common drugs used Method of action Choice of medications
3 Heart Failure Aims; Short term: Long term: Symptomatic / stabilise Mortality and morbility Chronic vs Acute management What is the treatment of acute heart failure?
4 Acute Heart Failure Oxygen (high flow) Diuretic (Furosemide 20-50mg IVI) Morphine 5-10mg IV (reduce anxiety and cause vasodilatation) GTN infusion mcg/min (venodilatation) Consider - CPAP / Inotropes / HDU or ITU
5 Heart Failure - chronic Lifestyle Smoking / exercise / diet / weight loss Pharmacological Diuretics ACEi / ARB Beta-blockers Digoxin Other meds This lecture Devices Cardiac resynchronisation / ICDs Heart transplantation
6 Hypertension Lifestyle Smoking / exercise / diet / weight loss Pharmacological ACEi / ARBs Calcium Channel Blockers Diuretics Specific Algorithm This lecture Special Circumstances
7 Renin-angiotensin system In response to low BP Angiotensin converting enzyme (via lungs and vasculature)
8 Renin-angiotensin system In response to low BP Angiotensin converting enzyme (via lungs and vasculature)
9 ACE-inhibitors Mode of Action (vasodilatation and natriuresis) Inhibition of Angiotensin I -> Angiotensin 2 (a vasoconstrictor) Stop bradykinin degradation (a vasodilator)-?cause of wide SE Vasodilatation- reducing preload and after load and reduce aldosterone so promotes excretion of Na/H20 by kidneys to reduce blood volume/pressure Side effects (due to poor receptor specificity) First Dose Hypotension Deterioration of renal function / Hyperkalaemia Dry cough Angio-oedema Examples (-pril) Perindopril/Enalapril/Ramipril/Lisinopril
10 Renin-angiotensin system In response to low BP Angiotensin converting enzyme (via lungs and vasculature)
11 Angiotensin II Receptor Antagonists (ARBs) Mode of Action (similar to ACEi) Selectively block angiotensin 2 Decreased peripheral vascular resistance DO NOT affect bradykinin degradation Side effects (due to poor receptor specificity) Rare Angio-oedema may still occur Examples (-sartan) Losartan / Candesartan / Valsartan
12 B-Blockers Mode of Action (Sympatholytic) Reduce effects of sympathetic nervous system and the RAS Reduce cardiac contraction and lower heart rate Used in H.failure, not first line in HTN Side effects AV Block Glucose intolerance Bronchospasm (un-selectivity) Examples Bisoprolol / metoprolol / propanolol / atenolol
13 Calcium Channel Blockers Dihydropyridines e.g. Amlodipine / Nifedipine HTN Non-dihydropyridines e.g. Verapamil / Diltiazem Angina
14 Calcium Channel Blockers- Dihydropyridines Mode of Action Work on smooth muscles Reduce systemic vascular resistance and arterial pressure Side effects Headache, hypotension, tachycarida, flushing
15 Calcium Channel Blockers- Non-Dihydropyridines Mode of Action VERAPAMIL Relatively selective to the myocardium and less systemically acting Very important in treatment of angina and arrhythmias DILTIAZEM Intermediate between verapamil and dihydropyridines in selectivity for vascular Ca channels Side effects Bradycardia, AV block, reduced cardiac contractility AVOID IN HEART FAILURE
16
17 Diuretics- Thiazides Mode of Action - Used for HTN Block Na reabsorption in the distal convoluted tubule by inhibiting the Na/Cl co-transporter Work within 1-2hrs and last 24hrs Side effects Hypokalaemia / Hypomagnesaemia Impaired glucose tolerance / Hypercholesterolaemia Examples Bendroflumethiazide / Indapamide
18 Diuretics- Loop diuretics Mode of Action - Used for H.Failure. Rarely for HTN Block Na reabsorption in the thick ascending loop of Henle through inhibiting Na/K/Cl co-transporter Work within 1-2 hrs and last 24hrs Side effects Hypotension Renal impairment Hypokalaemia / Hyponatraemia / Hypomagnesaemia Examples Furosemide / Bumetanide
19 Renin-angiotensin system In response to low BP Angiotensin converting enzyme (via lungs and vasculature) Aldosterone antagonists
20 Diuretics - Potassium-Sparing Mode of Action Aldosterone antagonist Side effects Hyperkalaemia Gynaecomastia Examples Spironolactone / Amiloride
21 Other medications Ivabridine Has affect on the F-channels in AV Node Lowers HR Indicated in treatment of Angina Recently added to NICE for NYHA class II-IV stable CHF only by specialist team
22 Special Circumstance- PREGNANCY METHYL-DOPA Stimulate central receptors to decrease peripheral sympathetic tone to reduce systemic vascular resistance with mild reduction of CO / HR S/e - Bradycardia / Postural hypotension HYDRALAZINE Short-acting potent vasodilator S/e - Reflex tachycardia (usually used with Beta blocker) - Hydralazine- headache, SLE-like syndrome LABETOLOL Both alpha and beta blocking activity S/e - postural hypotension / hepatocellular damage
23 Cases - all persistent readings 60yo Caucasian pt BP 170/95 50yo Black pt with IDDM on Amlodpine BP 150/90 40yo Caucasian pt BP 145/96 50yo Caucasian pt on Ramipril BP 150/90 50yo Black pt BP 174/97 50yo Caucasian pt with IDDM BP 145/95 What treatment would you give???
24 Hypertension Drug therapy indicated if: Persistent BP of > 160/100 mmhg OR > 140/90 mmhg with and raised CV risk or DM (10-year CVD risk of >20%/ existing CVD or target organ damage). Aim to reduce to BP to: < 140/90 mmhg in non-dm pts OR 130/80 mmhg in DM pts
25
26 Cases - all persistent readings 60yo Caucasian pt BP 170/95 AGE: Start on Calcium Channel Blocker 50yo Black pt with IDDM on Amlodpine BP 150/90 ETHNICITY and DM: On CCB so add ACEi 40yo Caucasian pt BP 145/94 Below target BP: Conservative Management- lifestyle and repeat in 6 months 50yo Caucasian pt on Ramipril BP 150/90 Still above target BP: On ACEi so add Calcium channel blocker 50yo Black pt BP 174/97 ETHNICITY and above target BP: Start Calcium channel blocker 50yo Caucasian pt with IDDM BP 145/95 DM and above target BP: Start ACEi
27 Heart Failure- CHRONIC Best medication for SYMPTOMS? Which medications shown to improve MORTALITY?
28
29 Heart Failure Loop Diuretics SYMPTOMATIC: minimum effective dose adding different diuretic if required to work synergistically ACEi - improve mortality and symptoms. Need to check U+Es. Beta-Blockers- improve mortality and hospitalisation Aldosterone blocker- e.g. spirononlactone reduces mortality in severe HF Digoxin- positive inotropic effect improve symptoms. NO MORTALITY improvement. SE include nephrotoxicity
30 Summary This lecture only meds- remember other treatment options Understand mechanisms Review algorithms Be aware of key S/E QUESTIONS??
Hypertension Guidelines
Overview Hypertension Guidelines Aim to reduce Blood Pressure to 140/90 or less (140/80 for diabetics), adding drugs as needed until further treatment is inappropriate or declined. N.B. patients do not
Milwaukee School of Engineering [email protected]. Case Study: Factors that Affect Blood Pressure Instructor Version
Case Study: Factors that Affect Blood Pressure Instructor Version Goal This activity (case study and its associated questions) is designed to be a student-centered learning activity relating to the factors
CHAPTER 8 ANTIHYPERTENSIVE DRUGS
CHAPTER 8 ANTIHYPERTENSIVE DRUGS Classification 1. Diuretics. 2. Beta adrenergic blockers. 3. Calcium channel blockers. 4. Angiotensin converting enzyme inhibitors. 5. Angiotensin receptor blockers. 6.
HYPERTENSION ASSOCIATED WITH RENAL DISEASES
RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein
Drug Treatment in Type 2 Diabetes with Hypertension
Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk
Cardiovascular System & Its Diseases. Lecture #4 Heart Failure & Cardiac Arrhythmias
Cardiovascular System & Its Diseases Lecture #4 Heart Failure & Cardiac Arrhythmias Dr. Derek Bowie, Department of Pharmacology & Therapeutics, Room 1317, McIntyre Bldg, McGill University [email protected]
Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
Guidance for Industry Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims
Guidance for Industry Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research
Universitätsklinik für Kardiologie. Test. Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie [email protected] 1
Test Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie [email protected] 1 Heart Failure - Definition European Heart Journal (2008) 29, 2388 2442 Akute Herzinsuffizienz Diagnostik und
Antihypertensive Drug Management to Achieve Systolic Blood Pressure <120 mmhg in SPRINT
Antihypertensive Drug Management to Achieve Systolic Blood Pressure
Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8)
Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) Adapted by Capital Health Plan Approved by Quality Improvement
ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE
I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.
Inpatient Heart Failure Management: Risks & Benefits
Inpatient Heart Failure Management: Risks & Benefits Dr. Kenneth L. Baughman Professor of Medicine Harvard Medical School Director, Advanced Heart Disease Section Brigham & Women's Hospital Harvard Medical
EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS
EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS Steven T. Johnson, PhD 1 Introduction The prevalence of chronic diseases like cardiovascular
Cardiovascular Risk in Diabetes
Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,
Hypertension and Diabetes
Hypertension and Diabetes C.W. Spellman, D.O., Ph.D., FACOI Professor & Associate Dean Research Dir. Center Diabetes & Metabolic Disorders Texas Tech University Health Science Center Midland-Odessa, Texas
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE
SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE Summary Heart failure has a worse prognosis than many cancers with an annual mortality of 40% in the first year following diagnosis and 10% thereafter.
1 Congestive Heart Failure & its Pharmacological Management
Harvard-MIT Division of Health Sciences and Technology HST.151: Principles of Pharmocology Instructor: Prof. Keith Baker 1 Congestive Heart Failure & its Pharmacological Management Keith Baker, M.D., Ph.D.
Heart Failure: Diagnosis and Treatment
Heart Failure: Diagnosis and Treatment Approximately 5 million people about 2 percent of the U.S. population are affected by heart failure. Diabetes affects 20.8 million Americans and 65 million Americans
DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Elhami et al. SJIF Impact Factor 5.210 Volume 4, Issue 11, 1159-1166 Research Article ISSN 2278 4357 DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal. Drugs for the treatment of pulmonary arterial hypertension
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Drugs for the treatment of Remit / Appraisal objective: Final scope To appraise the clinical and cost effectiveness of
Hypertension in anaesthesia Dr Antonia C. Mayell Royal Devon and Exeter Hospital UK Email [email protected]
Hypertension in anaesthesia Dr Antonia C. Mayell Royal Devon and Exeter Hospital UK Email [email protected] Self assessment Complete the following questions before reading this tutorial. 1. A 65yr
ACLS PHARMACOLOGY 2011 Guidelines
ACLS PHARMACOLOGY 2011 Guidelines ADENOSINE Narrow complex tachycardias or wide complex tachycardias that may be supraventricular in nature. It is effective in treating 90% of the reentry arrhythmias.
HYPERTENSION MANAGEMENT
DISCLAIMER: These guidelines were prepared jointly by the Surgical Critical Care and Medical Critical Care Services at Orlando Regional Medical Center. They are intended to serve as a general statement
Easy or complex? University Pharmacy. Pharm.D. candidates, 2011
High Blood Pressure Easy or complex? University Pharmacy Edwin Elliot, Insia Hussain Pharm.D. candidates, 2011 The evolution of mankind 2.5 mn years 50 years and we wonder why our healthcare costs are
Pharmacotherapy Primer
Pharmacotherapy Primer Based on the ACC/AHA 2005 Guideline Update Learn and LiveSM Diagnosis and Management of Chronic Heart Failure in the Adult Special thanks to Distributed through support from GlaxoSmithKline.
Case Study 6: Management of Hypertension
Case Study 6: Management of Hypertension 2000 Scenario Mr Ellis is a fit 61-year-old, semi-retired market gardener. He is a moderate (10/day) smoker with minimal alcohol intake and there are no other cardiovascular
Inotropes/Vasoactive Agents Hina N. Patel, Pharm.D., BCPS Cathy Lawson, Pharm.D., BCPS
Inotropes/Vasoactive Agents Hina N. Patel, Pharm.D., BCPS Cathy Lawson, Pharm.D., BCPS 1. Definition -an agent that affects the contractility of the heart -may be positive (increases contractility) or
Here is a drug list that you need to know before taking the NREMT-P exam!! Taken from the book EMS NOTES.com
Here is a drug list that you need to know before taking the NREMT-P exam!! Taken from the book EMS NOTES.com Special thanks to the number #1 internet training site id44.com and also to (NOTE) Please remember
Board Review: Hypertension Cases
Board Review: Hypertension Cases Cheryl L. Laffer, MD, PhD, FAHA Associate Professor of Medicine, Texas A&M HSC College of Medicine Senior Staff, S&W Nephrology / Hypertension (Remember, I didn t make
Ischemic Heart Disease: Angina Pectoris
Ischemic Heart Disease: Angina Pectoris Robert J. Straka, Pharm.D. FCCP Associate Professor University of Minnesota College of Pharmacy Minneapolis, Minnesota, USA [email protected] Learning Objectives
Blood Pressure Regulation
Blood Pressure Regulation Graphics are used with permission of: Pearson Education Inc., publishing as Benjamin Cummings (http://www.aw-bc.com) Page 1. Introduction There are two basic mechanisms for regulating
Treatment of Hypertension: JNC 8 and More
PL Detail-Document #300201 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER February 2014 Treatment of
DOI: 10.1111/jch.12237. Official Journal of the American Society of Hypertension, Inc. The Journal of Clinical Hypertension 1
ASH PAPER Clinical Practice Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension Michael A. Weber,
Special Communication
Clinical Review & Education Special Communication 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National
Diabetic Nephropathy
Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal
Hypertension Treatment Protocol
Hypertension Treatment Protocol Need at least one baseline BP with one Pulse value, on 2 different days (if possible), to diagnose HTN. Exception: If need to please patient with some treatment and encourage
The Relationship between Medication Use and Falls. Norma J. Owens, PharmD, FCCP, BCPS Professor College of Pharmacy University of Rhode Island
The Relationship between Medication Use and Falls Norma J. Owens, PharmD, FCCP, BCPS Professor College of Pharmacy University of Rhode Island Objectives for this morning Provide a framework to more fully
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Isoproterenol Major Indications Status Asthmaticus As a last resort for
Adrenergic, Adrenergic Blockers, Cholinergic and Cholinergic Blockers
Adrenergic, Adrenergic Blockers, Cholinergic and Cholinergic Blockers Objective 1: Explain the difference between the sympathetic and parasympathetic nervous systems Autonomic Nervous System Sympathetic
Drug treatment of elevated blood pressure
Drug treatment of elevated blood pressure Mark Nelson, Professor and Chair, Discipline of General Practice Professorial Research Fellow, and Senior Member, Menzies Research Institute, University of Tasmania,
STAGES OF SHOCK. IRREVERSIBLE SHOCK Heart deteriorates until it can no longer pump and death occurs.
STAGES OF SHOCK SHOCK : A profound disturbance of circulation and metabolism, which leads to inadequate perfusion of all organs which are needed to maintain life. COMPENSATED NONPROGRESSIVE SHOCK 30 sec
Hypertension Guideline V4
Hypertension Guideline V4 Approved 24/06/2008 Version VERSION 4 FINAL Date of First Issue 26/02/08 Review Date 01/03/2010 Date of Issue 24/06/2008 EQIA Yes / No 24/06/2008 Author / Contact Dr Leslie Cruickshank
PULMONARY HYPERTENSION. Charles A. Thompson, M.D., FACC, FSCAI Cardiovascular Institute of the South Zachary, Louisiana
PULMONARY HYPERTENSION Charles A. Thompson, M.D., FACC, FSCAI Cardiovascular Institute of the South Zachary, Louisiana What is Pulmonary Hypertension? What is normal? Pulmonary artery systolic pressure
Autonomic Nervous System
MOST FREQUENTLY USED DRUG CATEGORIES FOR AUTONOMIC SYSTEM THERAPY Beta 1 Adrenergic Blockers (Anatgonists) - Work on the Heart Beta 1 Adrenergic receptors are typically found on the heart and is a means
Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
HYPERTENSION: Comparison of New Guidelines
HYPERTENSION: Comparison of New Guidelines L. Brian Cross, PharmD, BCACP, CDE Vice-Chair & Associate Professor Bill Gatton College of Pharmacy Department of Pharmacy Practice Associate Professor James
Correspondence to: Rima B Shah ([email protected]) DOI: 10.5455/ijmsph.2013.2.167-172 Received Date: 29.11.2012 Accepted Date: 03.12.
RESEARCH ARTICLE STUDY OF UTILIZATION PATTERN OF ANTI-HYPERTENSIVE DRUGS IN HYPERTENSIVE DIABETIC PATIENTS WITH OR WITHOUT REDUCED RENAL FUNCTION AT TERTIARY CARE TEACHING HOSPITAL Jay Shah 1, Tejas Khakhkhar
Blood Pressure Medication. Barbara Pfeifer Diabetes Programs Manager
United Indian Health Services Blood Pressure Medication Titration Program Barbara Pfeifer Diabetes Programs Manager Why a Medication titration program? Despite the many antihypertensive medications available,
Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose
Current Management of Atrial Fibrillation Mary Macklin, MSN, APRN Concord Hospital Cardiac Associates DISCLOSURES I have no financial conflicts to disclose Book Women: Fit at Fifty. A Guide to Living Long.
!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing!
ADRENALINE IVI BOLUS IV Open a vial of 1:1000 ADRENALINE 1 mg /ml Add 1 ml to 9 ml N/Saline = 1mg adrenaline in 10 ml (or 100 mcg/ml) Add 1 ml 1:10,000 to 9 ml N/Saline = 100 mcg adrenaline in 10 ml (or
Renal Blood Flow GFR. Glomerulus Fluid Flow and Forces. Renal Blood Flow (cont d)
GFR Glomerular filtration rate: about 120 ml /minute (180 L a day) Decreases with age (about 10 ml/min for each decade over 40) GFR = Sum of the filtration of two million glomeruli Each glomerulus probably
Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD
Chronic Kidney Disease and the Electronic Health Record Duaine Murphree, MD Sarah M. Thelen, MD Definition of Chronic Kidney Disease (CKD) Defined by the National Kidney Foundation Either a decline in
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic
ADRENERGIC AND ANTI-ADRENERGIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
ADRENERGIC AND ANTI-ADRENERGIC DRUGS Mr. D.Raju, M.pharm, Lecturer SYMPATHETIC NERVOUS SYSTEM Fight or flight response results in: 1. Increased BP 2. Increased blood flow to brain, heart and skeletal muscles
JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014
JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates January 30, 2014 GOALS Review key recommendations from recently published guidelines on blood pressure and cholesterol management Discuss
Efficacy and Safety of Pharmacological Options for Rate Control in Atrial Fibrillation
AACN Advanced Critical Care Volume 23, Number 2, pp.120 125 2012, AACN ECG Challenges Earnest Alexander, PharmD, and Gregory M. Susla, PharmD Department Editors Efficacy and Safety of Pharmacological Options
Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital
Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI
Combination Antihypertensive Therapy: When to use it Diabetes
Combination Antihypertensive Therapy: When to use it Diabetes George L. Bakris, MD, F.A.S.N., F.A.S.H. Professor of Medicine Director, ASH Comprehensive Hypertension Center The University of Chicago Medicine
Guideline for Microalbuminuria Screening
East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network
Getting the most from blood pressure medicines
P R E S S U R E P O I N T S S E R I E S : NO. 4 Getting the most from blood pressure medicines B L O O D P R E S S U R E A S S O C I AT I O N Pressure Points series Pressure Points is a series of booklets
Biology 224 Human Anatomy and Physiology II Week 8; Lecture 1; Monday Dr. Stuart S. Sumida. Excretory Physiology
Biology 224 Human Anatomy and Physiology II Week 8; Lecture 1; Monday Dr. Stuart S. Sumida Excretory Physiology The following ELEVEN slides are review. They will not be covered in lecture, but will be
Pulmonary Diseases. Lung Disease: Pathophysiology, Medical and Exercise Programming. Overview of Pathophysiology
Lung Disease: Pathophysiology, Medical and Exercise Programming Overview of Pathophysiology Ventilatory Impairments Increased airway resistance Reduced compliance Increased work of breathing Ventilatory
Atrial Fibrillation Management Across the Spectrum of Illness
Disclosures Atrial Fibrillation Management Across the Spectrum of Illness NONE Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University Objectives AF Discuss the pathophysiology, diagnosis,
ADVICE FOR PATIENTS ON HEART MEDICATIONS
ADVICE FOR PATIENTS ON Contents: Introduction... 2 Drugs that ease chest pain... 4 Drugs that lower blood pressure... 6 Drugs that help an irregular heartbeat... 11 Drugs that lower Cholesterol... 14 Drugs
Cardiovascular Drugs Throughout the Continuum of Care
Cardiovascular Drugs Throughout the Continuum of Care Heart Arteries Veins Volume Carol Jacobson RN, MN www.cardionursing.com Drugs that keep blood from clotting: ASA Plavix Reopro, Integrilin, Aggrastat
Ngaire has Palpitations
Ngaire has Palpitations David Heaven Cardiac Electrophysiologist/Heart Rhythm Specialist Middlemore, Auckland City and Mercy Hospitals Auckland Heart Group MCQ Ms A is 45, and a healthy marathon runner.
ACLS Cardiac Arrest Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767
ACLS Cardiac Arrest Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767 Copyright 2010 American Heart Association ACLS Cardiac Arrest Circular Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767
UPMC HEALTH PLAN MANAGEMENT OF HEART FAILURE WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: CLINICAL PRACTICE GUIDELINE
General Statement on UPMC Health Plan Clinical Practice Guidelines: UPMC Health Plan develops clinical practice guidelines to support the practice of evidence-based medicine. The guidelines are from recognized
HEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise
WEEK 3 SUPPLEMENT HEART HEALTH A Beginner s Guide to Cardiovascular Disease HEART FAILURE Heart failure can be defined as the failing (insufficiency) of the heart as a mechanical pump due to either acute
1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA
1p36 and the Heart John Lynn Jefferies, MD, MPH, FACC, FAHA Director, Advanced Heart Failure and Cardiomyopathy Services Associate Professor, Pediatric Cardiology and Adult Cardiovascular Diseases Associate
Evaluation of anti-hypertensive drug utilisation and cost in Hospital Tengku Ampuan Afzan, Kuantan.
Evaluation of anti-hypertensive drug utilisation and cost in Hospital Tengku Ampuan Afzan, Kuantan. Azarisman SMS a,e, Aszrin A b, Sahimi M d, Ngow HA a,e, Marzuki AO a, Jamalludin AR c, Sapari S d and
GUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS. (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support)
AUSTRALIAN RESUSCITATION COUNCIL GUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support) The term cardiac arrhythmia
Disease Management for. Heart Failure
Disease Management for Heart Failure DISCLAIMER: The information contained in this annotated bibliography was obtained from the publications listed. The National Pharmaceutical Council (NPC) has worked
The 365-day period begins with the first dispensing transaction for each Ontario Drug Benefit (ODB) recipient on or after October 1, 2015.
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Chronic-use Medications List by In accordance with subsection 18 (11.1) of Ontario Regulation 201/96 made under the Ontario Drug Benefit
Chronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1
Chronic Kidney Disease (CKD) Algorithm Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm (See NICE Clinical Guideline CG73 1 and Quality Standards 2 ) Who should have
The new Heart Failure pathway
The new Heart Failure pathway An integrated and seamless Strategy Dr Sunil Balani Definition of Heart Failure The inability of the heart to pump blood at a rate commensurate with the requirements of metabolising
Pharmacology - Problem Drill 06: Autonomic Pharmacology - Adrenergic System
Pharmacology - Problem Drill 06: Autonomic Pharmacology - Adrenergic System Question No. 1 of 10 Instructions: (1) Read the problem and answer choices carefully, (2) Work the problems on paper as 1. What
Acute Renal Failure. usually a consequence.
Acute Renal Failure usually a consequence www.philippelefevre.com Definitions Pathogenisis Classification ICU Incidence/ Significance Treatments Prerenal Azotaemia Blood Pressure Cardiopulmonary Baroreceptors
Key Points. Autonomic Nervous System Drugs. Autonomic effects Sympathetic. Drugs can modify ANS activity by: Autonomic Nervous System
Key Points Autonomic Nervous System Drugs Autonomic drugs work at the synapses, Drugs either suppress or magnify the sympathetic or parasympathetic effect, Drugs don t work on a single target organ so
Atrial Fibrillation The Basics
Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation
2015 RN.ORG, S.A., RN.ORG, LLC
Heart Failure WWW.RN.ORG Reviewed August 2015, Expires August, 2017 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2015 RN.ORG, S.A., RN.ORG, LLC By Wanda
Select the one that is the best answer:
MQ Kidney 1 Select the one that is the best answer: 1) n increase in the concentration of plasma potassium causes increase in: a) release of renin b) secretion of aldosterone c) secretion of H d) release
SAVE ON MEDICAL SERVICES and PRESCRIPTION DRUGS for ongoing conditions
SAVE ON MEDICAL SERVICES and PRESCRIPTION DRUGS for ongoing conditions With Dickinson College s Value Based Insurance Design (VBID) If you have an ongoing condition, you can live well. You will need to
COMPARING TWO KINDS OF BLOOD PRESSURE PILLS:
COMPARING TWO KINDS OF BLOOD PRESSURE PILLS: ACEIs and ARBs A Guide for Adults Fast Facts ACEIs and ARBs are two of the many kinds of blood pressure pills. Both kinds of pills (ACEIs and ARBs) do a good
